FPF
IRWD icon

First Pacific Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Pacific Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-89
Closed -$776 – 430
2024
Q1 		$776 Buy
89
+19
+27% +$231 ﹤0.01% 401
2023
Q4 		$801 Buy
+70
New +$692 ﹤0.01% 355

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

First Pacific Financial's IRWD Position: Q2 2024 in Review

First Pacific Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 89 shares — an estimated $776 sold.

First Pacific Financial first reported a position in IRWD in Q4 2023 and held it in 2 quarters. The position peaked at $801 in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • First Pacific Financial reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • First Pacific Financial sold 89 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $776.
  • First Pacific Financial first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • First Pacific Financial's Ironwood Pharmaceuticals position peaked at $801 in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on First Pacific Financial's 13F filing for Q2 2024, filed 19 Jul 2024.